Camber Pharma Launches Generic Pepcid® Famotidine Tablets are indicated in adult and pediatric patients 88lb […]
Piscataway, NJ, June 2, 2022–Camber Pharmaceuticals is pleased to announce the addition of Oxcarbazepine Tablets to their current […]
Piscataway, NJ, June 1, 2022–Camber Pharmaceuticals is pleased to announce the addition of Famotidine Tablets […]
Camber’s parent company, Hetero, a global pharmaceutical leader, recently unveiled a new logo and brand […]
Piscataway, NJ, May 16, 2022–Camber Pharmaceuticals is pleased to announce the addition of Efavirenz, Emtricitabine and […]
Piscataway, NJ, May 11, 2022–Camber Pharmaceuticals is pleased to announce the addition of Atazanavir Capsules to their […]
Camber’s parent company, Hetero Drugs donated much needed medicines to Ukrainian clinics, public organizations, and […]